In vivo evidence for epidermal growth factor receptor (EGFR)-mediated release of prolactin from the pituitary gland.
Ontology highlight
ABSTRACT: Members of the epidermal growth factor receptor (EGFR/ERBB) system are essential local regulators of mammary gland development and function. Emerging evidence suggests that EGFR signaling may also influence mammary gland activity indirectly by promoting the release of prolactin from the pituitary gland in a MAPK and estrogen receptor-α (ERα)-dependent manner. Here, we report that overexpression of the EGFR ligand betacellulin (BTC) causes a lactating-like phenotype in the mammary gland of virgin female mice including the major hallmarks of lactogenesis. BTC transgenic (BTC-tg) females showed reduced levels of prolactin in the pituitary gland and increased levels of the hormone in the circulation. Furthermore, treatment of BTC-tg females with bromocriptine, an inhibitor of prolactin secreti
SUBMITTER: Dahlhoff M
PROVIDER: S-EPMC3234754 | biostudies-literature | 2011 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA